Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lovaza in Acute Myocardial Infarction
NCT01155336Phase 2Terminated
- Sponsor
- University of Rochester
- Start
- Jun 2010
- Primary completion
- May 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of eicosapentaenoic acid + docosahexaenoic acid in myocardial infarction (MI), sponsored by University of Rochester. Started Jun 2010; status: terminated.
02
Drugs
eicosapentaenoic acid + docosahexaenoic acid
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on NCT01155336.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01155336.